Code. Go. chevron pointing right

mRNA THAT TREAT CELLS SELECTIVELY.
LNP THAT REACH CELLS WITH VERSATILITY.

Meet mRNA 2.0

Elegantly designed.
Selectively translated.

We program mRNAs that can be read into therapeutic proteins selectively in target cells. They’re complemented by a clinically validated delivery system that drives them to the target tissue. The combined result is a novel class of therapies that are more efficacious and tolerable than standard of care.

graphic of encoding instructions that can be selectively read by the cells we target, mRNA promotes healing and suppresses disease
diagram of mRNA activated in microglial cells, regeneration promoted, and mrNA activated in
      malignant cells, cancer suppressed

The right tissue.
The right cell.

Legacy approaches to mRNA design are poor at targeting specific cells within tissue and tumor microenvironments. Fuzzy cell selection is a key barrier to therapeutic relevance.

Selective translation is the kernel of mRNA 2.0.

See how it works

Latest News